Literature DB >> 31515109

SETD5 Regulates Chromatin Methylation State and Preserves Global Transcriptional Fidelity during Brain Development and Neuronal Wiring.

Alessandro Sessa1, Luca Fagnocchi2, Giuseppina Mastrototaro3, Luca Massimino3, Mattia Zaghi3, Marzia Indrigo3, Stefano Cattaneo4, Davide Martini5, Chiara Gabellini5, Cecilia Pucci6, Alessandra Fasciani7, Romina Belli8, Stefano Taverna4, Massimiliano Andreazzoli5, Alessio Zippo9, Vania Broccoli10.   

Abstract

Mutations in one SETD5 allele are genetic causes of intellectual disability and autistic spectrum disorders. However, the mechanisms by which SETD5 regulates brain development and function remain largely elusive. Herein, we found that Setd5 haploinsufficiency impairs the proliferative dynamics of neural progenitors and synaptic wiring of neurons, ultimately resulting in behavioral deficits in mice. Mechanistically, Setd5 inactivation in neural stem cells, zebrafish, and mice equally affects genome-wide levels of H3K36me3 on active gene bodies. Notably, we demonstrated that SETD5 directly deposits H3K36me3, which is essential to allow on-time RNA elongation dynamics. Hence, Setd5 gene loss leads to abnormal transcription, with impaired RNA maturation causing detrimental effects on gene integrity and splicing. These findings identify SETD5 as a fundamental epigenetic enzyme controlling the transcriptional landscape in neural progenitors and their derivatives and illuminate the molecular events that connect epigenetic defects with neuronal dysfunctions at the basis of related human diseases.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  SETD5; autism spectrum disorders; epigenetics; intellectual disability; neural development

Mesh:

Substances:

Year:  2019        PMID: 31515109     DOI: 10.1016/j.neuron.2019.07.013

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  25 in total

1.  A High-Throughput Chromatin Immunoprecipitation Sequencing Approach to Study the Role of MYC on the Epigenetic Landscape.

Authors:  Luca Fagnocchi; Alessio Zippo
Journal:  Methods Mol Biol       Date:  2021

Review 2.  Epigenetics and beyond: targeting writers of protein lysine methylation to treat disease.

Authors:  Kamakoti P Bhat; H Ümit Kaniskan; Jian Jin; Or Gozani
Journal:  Nat Rev Drug Discov       Date:  2021-01-19       Impact factor: 84.694

3.  Epigenetic evidence for distinct contributions of resident and acquired myonuclei during long-term exercise adaptation using timed in vivo myonuclear labeling.

Authors:  Kevin A Murach; Cory M Dungan; Ferdinand von Walden; Yuan Wen
Journal:  Am J Physiol Cell Physiol       Date:  2021-11-24       Impact factor: 4.249

4.  A MYT1L syndrome mouse model recapitulates patient phenotypes and reveals altered brain development due to disrupted neuronal maturation.

Authors:  Jiayang Chen; Mary E Lambo; Xia Ge; Joshua T Dearborn; Yating Liu; Katherine B McCullough; Raylynn G Swift; Dora R Tabachnick; Lucy Tian; Kevin Noguchi; Joel R Garbow; John N Constantino; Harrison W Gabel; Keith B Hengen; Susan E Maloney; Joseph D Dougherty
Journal:  Neuron       Date:  2021-10-05       Impact factor: 17.173

5.  Chromatin-mediated alternative splicing regulates cocaine-reward behavior.

Authors:  Song-Jun Xu; Sonia I Lombroso; Delaney K Fischer; Marco D Carpenter; Dylan M Marchione; Peter J Hamilton; Carissa J Lim; Rachel L Neve; Benjamin A Garcia; Mathieu E Wimmer; R Christopher Pierce; Elizabeth A Heller
Journal:  Neuron       Date:  2021-09-03       Impact factor: 18.688

6.  Developmental disruption to the cortical transcriptome and synaptosome in a model of SETD1A loss-of-function.

Authors:  Nicholas E Clifton; Matthew L Bosworth; Niels Haan; Elliott Rees; Peter A Holmans; Lawrence S Wilkinson; Anthony R Isles; Mark O Collins; Jeremy Hall
Journal:  Hum Mol Genet       Date:  2022-09-10       Impact factor: 5.121

Review 7.  The role of histone modifications: from neurodevelopment to neurodiseases.

Authors:  Jisu Park; Kyubin Lee; Kyunghwan Kim; Sun-Ju Yi
Journal:  Signal Transduct Target Ther       Date:  2022-07-06

8.  SETD5-Coordinated Chromatin Reprogramming Regulates Adaptive Resistance to Targeted Pancreatic Cancer Therapy.

Authors:  Zhentian Wang; Simone Hausmann; Ruitu Lyu; Tie-Mei Li; Shane M Lofgren; Natasha M Flores; Mary E Fuentes; Marcello Caporicci; Ze Yang; Matthew Joseph Meiners; Marcus Adrian Cheek; Sarah Ann Howard; Lichao Zhang; Joshua Eric Elias; Michael P Kim; Anirban Maitra; Huamin Wang; Michael Cory Bassik; Michael-Christopher Keogh; Julien Sage; Or Gozani; Pawel K Mazur
Journal:  Cancer Cell       Date:  2020-05-21       Impact factor: 31.743

9.  Neuronal SETD2 activity links microtubule methylation to an anxiety-like phenotype in mice.

Authors:  Matthias Koenning; Xianlong Wang; Menuka Karki; Rahul Kumar Jangid; Sarah Kearns; Durga Nand Tripathi; Michael Cianfrocco; Kristen J Verhey; Sung Yun Jung; Cristian Coarfa; Christopher Scott Ward; Brian Thomas Kalish; Sandra L Grimm; W Kimryn Rathmell; Ricardo Mostany; Ruhee Dere; Matthew Neil Rasband; Cheryl Lyn Walker; In Young Park
Journal:  Brain       Date:  2021-09-04       Impact factor: 15.255

10.  Loosening chromatin and dysregulated transcription: a perspective on cryptic transcription during mammalian aging.

Authors:  Brenna S McCauley; Weiwei Dang
Journal:  Brief Funct Genomics       Date:  2022-01-25       Impact factor: 4.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.